from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2451/-

LFCtreatmentdescriptionclass of inhibitor

0.852

Amikacinug/mL Amikacintranslation

0.327

Cap5-10ug/mL Capreomycintranslation

0.414

Rox10-50 ug/mL Roxithromycintranslation

0.923

SM2-5 ug/mL Streptomycintranslation

-2.809

Tet5-10 ug/mL Tetracyclinetranslation

0.762

Rif0.2-5ug/mL Rifampicintranscription

-0.157

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.511

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.204

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.038

CPZ10-50 ug/mL Chlorpromazinerespiration

0.182

Clofazimine10-13 ug/mL Clofaziminerespiration

0.169

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.428

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.911

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.613

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.464

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.749

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.177

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.573

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.031

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.903

Nigericin50 uM Nigericinrespiration

0.260

TRC10-150 ug/mL Triclosanrespiration

-0.071

TRZ10-25 ug/mL Thioridazinerespiration

-0.087

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.314

menadione6-10 ug/mL Menadionerespiration

0.518

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.473

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.500

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.066

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.037

NRP_1Non-replicating persistence stage 1dosRassociated

0.817

Amp0.2mg/mL AmpicillincellWall

-0.156

Cephalexin20-100 ug/mL CephalexincellWall

1.141

Cerulenin0.32-5 ug/mL CerulenincellWall

0.563

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.252

EMB10-20 ug/mL EthambutolcellWall

0.755

Eta12-40 ug/mL EthionamidecellWall

0.060

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.251

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.970

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.313

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.290

BZA0.12 mg/mL BenzamidearomaticAmides

-0.037

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.413

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.468

H2O24 mM hydrogen peroxideDNAdamaging

0.035

Levo10 ug/mL LevofloxacinDNAdamaging

0.008

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.890

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.689

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.281

UVUV-irradiationDNAdamaging

-0.183

ARP41-4 ug/mL Antitubercular compound ARP4?

0.351

Antimycin12.5-50 ug/mL Antimycin A?

-1.683

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.825

PA_110-50 ug/mL Antitubercular compound PA-1?

1.764

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.801

PA8240.2-2 ug/mL PA-824?

-0.389

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.274

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-2.165

Verapamil50 uM Verapamil?

-1.271

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.137

methoxatin10-20 ug/mL Methoxatin?